Comparison of oxidative stress indicators in plasma of recent-onset and long-term type 1 diabetic patients

Journal of Toxicology and Environmental Health - Part A

Volumn 59, Issue 1, 2000, Pages 7-14

  Guzel S ^a   Seven, Arzu ^a   Satman, I ^a   BurCak G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; LIPID HYDROPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; ONSET AGE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL;

ADULT; AGING; ALBUMINURIA; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; LIPID PEROXIDES; LIPIDS; MALE; OXIDATIVE STRESS; PHOSPHOLIPIDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 0034645794     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841000157032     Document Type: Article

References (28)

1. Abraham, E. C., Perry, R. E., and Stallings, M. 1983. Applications of affinity chromatography for separation and quantitation of glycosylated hemoglobins. J. Lab. Clin. Med. 102:187-197.
2. Altomare, E., Vendemiale, G., Chicco, D., Procacci, V., and Cirelli, F. 1992. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabetes Metab. 18:264-271.
3. Andersen, J. L., Rasmussen, L. M., and Ledet, T. 1996. Diabetic macroangiopathy and atherosclerosis. Diabetes 45:91-94.
4. Baginski, E. S., Epstein, E., and Zak, B. 1975. Lipids. In Practical clinical chemistry, ed. T. Ackerman, pp. 360-362. Boston: Little, Brown.
5. Baynes, J. W. 1994. Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412.
6. Berg, T. J., Nourooz-Zadeh, J., Wolff, S. P., Tritschler, H. J., Bangstad, H. J., and Hanssen, K. F. 1998. Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomised controlled study of IDDM patients with microalbuminuria. Diabetes Care 21:295-300.
7. Bird, R. P., Silas, S. A., Hing, O., Hadley, M., and Draper, H. H. 1983. Determination of malondi-aldehyde in biological materials by high-pressure liquid chromatography. Anal. Biochem. 128: 240-244.
8. Buege, J. A., and Aust, S. T. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302-310.
9. Cramer, G. L., Miller, J. F., Pentleton, R. B., and Lands, W. E. M. 1991. Iodometric measurement of lipid hydroperoxides in human plasma. Anal. Biochem. 193:204-211.
10. El-Saadani, M., Esterbauer, H., El-Sayed, M., Goher, M., Nassar, A. Y., and Jurgens, G. 1989. A spec-trophotometric assay for lipid peroxides in serum lipoproteins using commercially available reagent. J. Lipid Res. 30:627-630.
11. Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., and Greene, D. A. 1994. A practical two-step quantitative clinical and electrophysiologic assessment, diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1288.
12. Guigliano, O., and Ceriello, A. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267.
13. Görög, P., Kotak, D. C., and Kovacs, I. B. 1991. Simple and specific test for measuring lipid peroxides in plasma. J. Clin. Pathol. 44:765-767.
14. Griesmacher, A., Kindhauser, M., Andert, S. E., Schreiner, W., Toma, C., Knoebl, P., Petschmann, P., Prager, R., Schnack, C., Schernthaner, G., and Mueller, M. M. 1995. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am. J. Med. 98:469-475.
15. Gutteridge, J. M. C. 1995. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 41:1812-1828.
16. Gutteridge, J. M. C., and Halliwell, B. 1990. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Soc. 15:129-135.
17. 2+ in the presence of xyenol orange-comparison with the TBA assay and an iodometric method. Lipids 26:853-856.
18. Kohner, E. M., and Porta, M. 1992. Screening for diabetic retinopathy in Europe: A field guide book, pp. 295-303. Copenhagen: IDF &WHO Regional Office for Europe.
19. Losada, M., and Alio, J. L. 1996. Malondialdehyde serum concentration in type 1diabetic with and without retinopathy. Doc. Ophthalmol. 93:223-229.
20. Narup, J., Mandrup-Poulsen, T., Helquist, S., Andersen, H. U., Pociot, F., Rimers, I., Cuartero, B. G., Karlsen, A. E., Bjerre, U., and Lorezen, T. 1994. On the pathogenesis of IDDM. Diabetologia 37:82-89.
21. Pieper, G. M., Jordan, M., Dundlinger, L. A., Adams, M. B., and Roza, A. M. 1995. Peroxidative stress in diabetic blood vessels. Reversal by pancreatic islet transplantation. Diabetes 44:884-889.
22. Ruiz, C., Alegria, A., Barbera, R., Farre, R., and Lagarda, M. J. 1999. Lipid peroxidation and antioxidant enzyme activities in patients with type 1diabetes mellitus. Scand. J. Clin. Lab. Invest. 59: 99-105.
23. Salonen, J. T., Nyssönen, K., Tumainen, T., Maenpaa, P. H., Korpela, H., Kaplan, G. A., Lynch, J., Helmrich, S. P., and Salonen, R. 1995. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations. A four year follow up study in men. Br. Med. J. 311: 1124-1127.
24. Santini, S. A., Marra, G., Giardina, B., Cotroneo, P., Mordenta, A., Martorana, G. E., Manto, A., and Ghirlanda, G. 1997. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46:1853-1858.
25. Sinclair, A. J. 1993. Free radical mechanisms and vascular complications of diabetes mellitus. Diabetes Rev. 2:7-10.
26. Slater, T. I. 1984. Overview of methods used for detecting lipid peroxidation. Methods Enzymol. 105:283-293.
27. Wolff, S. P. 1993. Diabetes mellitus and free radicals. Br. Med. Bull. 49:642-652.
28. World Health Organization Study Group. 1985. Diabetes Mellitus. Tech. Rep. Ser. No. 727. Geneva: WHO.